Abstract:Purpose: Focal cartilage defects as a consequence of trauma are a major risk factor for the development of early onset osteoarthritis. These defects still pose a largely unresolved problem for the treating physician. Previously, we have developed an injectable in situ gelating hydrogel that can be applied in an arthroscopic procedure to fill up cartilage defects by simple injection. These hydrogels consist of hyaluronic acid - tyramine and dextran - tyramine conjugates that cross link in in a cell-friendly enzymatic, peroxidase-based reaction, initiated by non-toxic concentrations of H2O2. During the cross linking reaction the hydrogels co-valently attach to the cartilage resulting in strong bonding and fixation of the hydrogel in the defect. These hydrogels possess chemoattractant properties facilitating the ingrowth of cells as demonstrated in an ex vivo chondral plug model opening the possibility for cell-free cartilage repair. The aim of this study is to test the use of these injectable hydrogels for cartilage repair in an orthotopic chondral defect rabbit model side-by-side compared with autologous chondrocyte implantation. In addition, we evaluated the concept in an equine model for focal cartilage defects. Methods: Three male rabbits were sacrificed to establish cultures of primary human chondrocytes for implantation purposes. In a pilot rabbit experiment skeletally mature female rabbits were operated under anesthesia and two 4mm wide chondral defects were created in each knee joint. The defects were left untreated, filled up with hydrogel only, or with hydrogel prior mixed with chondrocytes. The various combinations of hydrogel precursors were injected in a liquid state in the defect and left to settle in a mild enzymatically mediated cross linking reaction which took place within less than 20 seconds. Rabbits were sacrificed 4 weeks and 10 weeks after treatment and tissues were collected for histology. In a pilot experiment two horses were operated under general anaesthesia in a fully arthroscopic procedure. In each knee joint, 5mm wide chondral defects were created. These defects were in the same arthroscopic procedure completely filled with the hydrogel. Synovial fluid was collected after 1, 2, 3, 5, 7 and 14 days after surgery. After two weeks horses were humanely euthanisized and tissue was processed for histology. Results: In pilot experiments in rabbits, chondral defects were completely repaired using the injectable hydrogels after 10 weeks of surgery. Cell-free hydrogels appeared as efficient as cell-containing hydrogels. The data are now confirmed in a larger study group in which treatment with hydrogels is compared to microfracture. In the equine model we demonstrated that the injectable hydrogels could be used to fill up focal chondral defects in an completely arthroscopic procedure. Synovial fluid sampling demonstrated a clinically not relevant small increase in white blood cell count and protein count in the first 2 days after surgery which returned to base-line after 3 to 5 days. Clinical examination and follow up of the operated joints demonstrated normal response to arthroscopic surgery: no adverse effects were noted demonstrating the safety of the procedure. The horses were able to make functional use of their treated legs within a few days and walked normally 2-weeks after surgery. At this time point visual inspection demonstrated the presence of hydrogels in each of the defects. Histological examination demonstrated the presence of cell layers on top of the hydrogel and invasion of cells into the hydrogel both from the top and the bottom. The invading cells were organized in columns, like in normal cartilage, and stained positive for typical chondrocyte markers. They actively deposited glycosaminoglycans. Conclusions: This study demonstrates the feasibility of developing an arthroscopic and completely cell-free treatment of chondral defects. It also demonstrates the presence of populations of migratory cells in the traumatized joint. These cells can actively migrate to and invade an appropriate scaffolding material in vivo and start the deposition of cartilage matrix. In the future, this work may translate into a biomaterial based regenerative treatment of osteoarthritis by harnessing the regenerative potential of these migratory cells.

Hydrogel‐Guided, rAAV‐Mediated IGF‐I Overexpression Enables Long‐Term Cartilage Repair and Protection against Perifocal Osteoarthritis in a Large‐Animal Full‐Thickness Chondral Defect Model at One Year In Vivo

Locally Directed Recombinant Adeno-Associated Virus–Mediated IGF-1 Gene Therapy Enhances Osteochondral Repair and Counteracts Early Osteoarthritis In Vivo

Thermosensitive Hydrogel Based on PEO–PPO–PEO Poloxamers for a Controlled In Situ Release of Recombinant Adeno‐Associated Viral Vectors for Effective Gene Therapy of Cartilage Defects

In Vivo Raav-Mediated Human TGF-β Overexpression Reduces Perifocal Osteoarthritis and Improves Osteochondral Repair in a Large Animal Model at One Year.

rAAV-Mediated Human FGF-2 Gene Therapy Enhances Osteochondral Repair in a Clinically Relevant Large Animal Model Over Time In Vivo

Cartilage-Targeting Mrna-Lipid Nanoparticles Rescue Perifocal Apoptotic Chondrocytes for Integrative Cartilage Repair

An Injectable Hydrogel Scaffold With Kartogenin-Encapsulated Nanoparticles for Porcine Cartilage Regeneration: A 12-Month Follow-up Study

Single Injection AAV2-FGF18 Gene Therapy Reduces Cartilage Loss and Subchondral Bone Damage in a Mechanically Induced Model of Osteoarthritis

A Photopolymerizable Biocompatible Hyaluronic Acid Hydrogel Promotes Early Articular Cartilage Repair In A Minipig Model In Vivo

Effects of rAAV-Mediated Overexpression of sox9 and TGF-ß via Alginate Hydrogel-Guided Vector Delivery on the Chondroreparative Activities of Human Bone Marrow-Derived Mesenchymal Stromal Cells

Injectable Enzymatically Cross Linkable Hydrogels: A Minimally Invasive Cell Free Approach to Regenerate Damaged Articular Cartilage

Alginate hydrogel-guided rAAV-mediated FGF-2 and TGF-β delivery and overexpression stimulates the biological activities of human meniscal fibrochondrocytes for meniscus repair

A novel method for the direct fabrication of growth factor-loaded microspheres within porous nondegradable hydrogels: Controlled release for cartilage tissue engineering

Experimental Study of Chitosan Mediated in Vivo Igf-1 Gene Transfection for the Treatment of Cartilage Defect (local Administration of Chitosan/igf-1 Complex Treat Cartilage Defect)

Platelet-rich Plasma Combined with Injectable Hyaluronic Acid Hydrogel for Porcine Cartilage Regeneration: a 6-Month Follow-Up

Cartilage lacuna-biomimetic hydrogel microspheres endowed with integrated biological signal boost endogenous articular cartilage regeneration

Injectable Mesenchymal Stem Cell Therapy for Large Cartilage Defects—A Porcine Model

Icariin-conditioned Serum Engineered with Hyaluronic Acid Promote Repair of Articular Cartilage Defects in Rabbit Knees

rAAV TGF-β and FGF-2 Overexpression via pNaSS-Grafted PCL Films Stimulates the Reparative Activities of Human ACL Fibroblasts

Enhanced chondrogenic phenotype of primary bovine articular chondrocytes in Fibrin-Hyaluronan hydrogel by multi-axial mechanical loading and FGF18

Fibrous Scaffolds with Varied Fiber Chemistry and Growth Factor Delivery Promote Repair in a Porcine Cartilage Defect Model